SENDCon | Oct. 10-12, 2023 | Atlanta, Georgia and Online

About the Southeastern Neurodegenerative Disease Conference (SENDCon)

SENDCon aims to build a network of collaboration among early career dementia researchers, scientists and students who work on Alzheimer’s disease, amyotrophic lateral sclerosis, chronic traumatic encephalopathy, frontotemporal dementias, Huntington’s disease, Parkinson’s disease, stroke, traumatic brain injury and other neurodegenerative disorders.

This hybrid conference, held virtually and in person, provided substantial opportunities for early career dementia researchers to give both oral and poster presentations alongside their senior colleagues, with the goal of cross-recruitment across participating institutions.

SENDCon focuses on the work of scientists in Alabama, Florida, Georgia, Kentucky, North Carolina, South Carolina, Tennessee, Virginia, Washington, D.C., and Puerto Rico — though neuroscience researchers from outside the region were also invited to register and attend.

View the 2023 conference program .

Conference Areas of Interest

Researchers were invited to submit an abstract for an oral or poster presentation at SENDCon. Areas of interest included:

  • Genetics, Modeling and Systems Biology.
  • Health Disparities and Diversity.
  • Neuroinflammation and Immunity.
  • Neuropathology, Neuroimaging and Diagnostics.
  • Proteostasis, Seeding/Spreading of Protein Aggregates.


Companies interested in sponsoring future conferences can contact Tommy Morris, Senior Director of Corporate Initiatives, at


General questions:
Media questions:

Get Email Updates on SENDCon

Conference Details

Dates: Oct. 10-12, 2023
Location: Atlanta, Georgia and online

Call for Abstracts

Abstract submission has closed.

Go Beyond the Conference

Network and collaborate year-round with ISTAART, a global community of scientists, clinicians and dementia professionals who are working to advance Alzheimer’s and dementia research and treatment.

ISTAART membership is free for students.

Learn More

Join the Conversation


We use cookies to improve your experience on this website. Learn about options for managing your personal data in our Privacy Policy.